Space Travel News  
Researchers Put The Bite On Mosquitoes

The researchers also envision developing an oral insecticide--a mosquito-slaying pill that members of a community with a high instance of, say, yellow fever or malaria might take to reduce the mosquito population. The pill wouldn't be a vaccine; if people who took it were later bitten by a disease-carrying mosquito, they would still become infected. However, the mosquito would ingest the insecticide along with the blood, causing her to bear fewer young and possibly die before she could bite anyone else.
by Staff Writers
Tempe AZ (SPX) Jan 17, 2008
Few things sting like a mosquito's bite--especially if that bite carries a disease such as malaria, yellow fever, Dengue fever or West Nile virus. But if researchers from The University of Arizona in Tucson have their way, one day mosquito bites may prove deadly to the mosquitoes as well.

"Our goal is to turn the female mosquito's blood meal into the last meal she ever eats," said project leader Roger L. Miesfeld, a professor of biochemistry and molecular biophysics in UA's College of Science and a member of BIO5 and the Arizona Cancer Center.

Other UA researchers involved with the project include Patricia Y. Scaraffia, Guanhong Tan, Jun Isoe, BIO5 member Vicki H. Wysocki, and the late Michael A. Wells.

These researchers have discovered that one particular mosquito species, Aedes aegypti, has a surprisingly complex metabolic pathway, one that requires its members to excrete toxic nitrogen after gorging on human blood. If the mosquitoes fail to do so, they'll also fail to lay eggs--and will likely sicken and die.

Scaraffia, a research assistant professor in UA's department of biochemistry and molecular biophysics, and the other members of the team published their findings in the January 15 issue of the Proceedings of the National Academy of Sciences. The research was funded by the National Institutes of Health.

Miesfeld and his colleagues are seeking a molecule that is harmless to humans, but will gum up the works of mosquito metabolism, forcing the mosquitoes to hang onto the nitrogen. Such a molecule would kill both the mosquitoes and their would-be progeny--thus slowing the spread of disease.

Once found, this molecule--and similar molecules aimed at other mosquito species--could be developed into an insecticide and sprayed in places where mosquitoes congregate, such as around water and on mosquito netting.

The researchers also envision developing an oral insecticide--a mosquito-slaying pill that members of a community with a high instance of, say, yellow fever or malaria might take to reduce the mosquito population. The pill wouldn't be a vaccine; if people who took it were later bitten by a disease-carrying mosquito, they would still become infected. However, the mosquito would ingest the insecticide along with the blood, causing her to bear fewer young and possibly die before she could bite anyone else.

"The whole community would essentially become one big mosquito trap," Miesfeld said. Over time, mosquito populations and disease rates would both decline. "It would be a group effort that in the long run could have a huge impact."

In a world where both mosquitoes and the diseases they carry are becoming increasingly resistant to known insecticides and medicines, finding new ways to fight them is crucial.

"This would be one more weapon in our arsenal against diseases that kill millions of people a year," Miesfeld said.

Related Links
University of Arizona
Epidemics on Earth - Bird Flu, HIV/AIDS, Ebola



Memory Foam Mattress Review
Newsletters :: SpaceDaily :: SpaceWar :: TerraDaily :: Energy Daily
XML Feeds :: Space News :: Earth News :: War News :: Solar Energy News


Monkey Malaria Widespread In Humans And Potentially Fatal
London UK (SPX) Jan 16, 2008
A potentially fatal species of malaria is being commonly misdiagnosed as a more benign form of the disease, thereby putting lives at risk, according to research funded by the Wellcome Trust and the University Malaysia Sarawak. Researchers in Malaysia studied more than 1,000 samples from malaria patients across the country.







  • Russian Rockets Circa 2008 Part Two
  • Russian rockets Circa 2008 Part One
  • ASRC Aerospace Contributes To NASA Constellation System
  • Japan's Mitsubishi Heavy aims to cut rocket launch costs: company

  • Thuraya-3 Satellite Successfully Launched To Orbit
  • Boosting Capability: Santa Maria Station To Join ESTRACK
  • Russia's First Space Launch Of 2008 Scheduled For January 28
  • Sea Launch Begins Countdown For Thuraya-3 Launch

  • NASA to televise Columbia remembrance
  • Shuttle Tank Connector Repairs Stretch Boundaries
  • NASA resets Atlantis shuttle launch to February 7
  • US shuttle glitches may delay Hubble mission

  • SPACEHAB And NASA Cooperating On Space Act Agreement For Use Of Space Station To Process Microgravity Products
  • Space station orbit shifted for shuttle arrival: report
  • Russian Spacecraft To Lift Off To ISS Two Days Early
  • International Space station set for busy spell

  • Environmental Tectonics NASTAR Center Announces Launch Of New Air And Space Adventure Programs
  • NASA inspector general comes under fire
  • ATK To Design And Build Solar Arrays For NASA's Orion CEV
  • SpaceDev Completes Completes Flight Test Plan For Dream Chaser

  • China Set To Launch Manned Space Mission In 2008
  • China Reports Fourteen Potential Astronauts In Training For Three Seats
  • ISRO Saw String Of Successes In 2007
  • First Chinese Satellite Conglomerate Beams Into Operation

  • Meet Blob The Robot
  • Russian Fuel Flows Into Jules Verne Automated Transfer Vehicle
  • ESA Training Team ATV
  • Honda's ASIMO robot gets smarter

  • Ice Clouds Put Mars In The Shade
  • Scientists examine effects of wind on Mars
  • 2007 WD5 Mars Collision Effectively Ruled Out As Impact Odds Widen To 1 In 10000
  • Russia claims to be ahead in race to put man on Mars

  • The content herein, unless otherwise known to be public domain, are Copyright Space.TV Corporation. AFP and UPI Wire Stories are copyright Agence France-Presse and United Press International. ESA Portal Reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space.TV Corp on any Web page published or hosted by Space.TV Corp. Privacy Statement